In places of low vaxn (23% in S Africa), hospitalizations rise with increasing cases with new variant; does not mean it is more virulent; means it is a COVID variant. Now 8 cases at least in US but likely much more (5 in NY, verified community spread) cnb.cx/3lpjnTE
Yesterday, WHO & S. Africa reported 90% of those in hospital were unvaccinated (meaning vaccines work); there is nothing nothing more important than getting vaccines out to the world (S. Africa 23% vax'd; surrounding countries less)
Watch carefully- current disconnect in trends in S. Africa, comparing cases and deaths. We expect lag but the increasing cases with omicron not showing the same patterns as with delta so may be clue of lower virulence. More data needed ourworldindata.org/explorers/coro…
Dr. Karim (we know well from HIV!) discusses how much testing ramped up in S Africa after identification of Omicron last week but seek & you will find - Omicron probably there & many other places before so if deaths not rising, good sign; watch hospitals bbc.co.uk/programmes/p0b…
In terms of more re-infections, antibodies decline with time from original infection (which occurred in 2020) (or original vaccine in early 2021) so can get more mild re-infections while you wait for your B cells to make more Abs & T cells protect from severe disease
So, a mild re-infection on top of former infection or vax (there were a lot of mild breakthroughs with delta) will give "hybrid immunity" but is prior infection or vax protecting from severe disease? Seems so and consistent with T/B cells, keep watching
In highly vaccinated countries like Europe & in the US (at least across many states), if we start using hospitalizations (have to be COVID hospitalizations though, for and not with) as our main metric for "success" (and restrictions like Marin County), good shift in strategy
As administration ramps up testing, limitations of our current tests will come up (PCR too sensitive; low viral load unclear significance; antigen tests false positives); seek & you will find virus in nose; looking at illness in high vax states (CA data here) of clinical import
US strategy: if start using hospitalizations as our main metric in high vax places, must give data 1) On status of vax, unvax'd, prior infected 2) On symptoms since we do COVID swabs on all for infection control- there with or for COVID? If latter, how ill theatlantic.com/health/archive…
I wrote this to CDC in delta (since places with high vax had hospitalizations "decoupled" from cases, but suggest each municipality in US in context of vax report data out on hospitalizations by vax/unvax (or prior infection), symptoms/no symptoms (with universal screening)
Finally, please remember what happened in the US with delta; places with high vax (Bay Area) had low rates of child illness even though 5-11 vaccine not out because adult vax protect kids; in S. Africa with 25% vax, kids not protected by adult vaccines; #globalvaxequity
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Yes, it is true that an attenuated virus (led to more mild symptoms) did help end the 1918 influenza pandemic as Dr. Friedland said; we will keep watching Omicron variant but important observation
I would like to add a comment as a long-standing HIV doctor & researcher. Many of us have worked with South African doctors & infectious diseases epidemiologists for decades; this verified by conversations with SA colleagues; amazing doctors, researchers, scientists; we are lucky
And many of us were in touch with Indian researchers, scientists and epidemiologists at the start of the delta wave there and this was not at all true; it was terrible (4% vaccination rate); so let's all keep watching; ambiguity hard; let's wait & see
Omicron COVID variant was in Europe before South African detected & flagged for world. Agree with AztraZeneca -no evidence vax doesn't protect from severe disease with variants (AZ less profit oriented); 2) S. Africa scientists that they felt 'punished' cbsnews.com/news/omicron-v…
This is some of the immunology behind why vaccines likely to still be protective against variants:
And the 2-dose vaccines seem to protect against severe disease per BioNtech; if you want to avoid mild breakthrough, certainly get boosted. With an endemic virus, virus will likely be seen again in future after booster antibodies come down wsj.com/articles/omicr…
3 characteristics to ask about a variant. Is it more transmissible, more virulent, can it evade vaccines? Delta was 1st, not second two. We don’t know enough about omicron but this is a thread on polyclonal antibodies and B/T cell immunity from vax that makes 3rd more unlikely
And agree with Dr. Katz that the most important thing to understand is the degree of symptoms (illness) from a new variant: preliminary reports on more mild need verification, more study just like the risk stratification by age in COVID so important linkedin.com/pulse/omicron-…
We know from HIV how incredibly amazing S. Africa scientists, doctors/ epidemiologists are; careful work should be commended, not punished. So far "presents mild disease with symptoms being sore muscles and tiredness" (cough, smell, taste not prominent) wionews.com/world/covid-om…
NU VARIANT (B.1.1.529) in South Africa & why unlikely to evade vaccine-induced immunity. So, what is this variant? Number 1, we don't know yet if it is more transmissible. Still being studied & described. 59 cases uploaded to database thenationalnews.com/coronavirus/20…
Okay, so what is a "variant" mean for COVID? Means mutations in spike protein that attaches the virus to the host cell: mutations that differ from the "ancestral strain". This is the bit of the virus that tends to mutate most (like H and N surface proteins of influenza). Also,
of the 8 vaccines approved by the WHO (Novavax will be added soon & will make the 9th), 6 of those 9 involve the spike protein in some way (either code for it with mRNA, DNA; Novavax is protein itself); 3 of the 9 are whole inactivated virions (Covaxin, Sinopharm, Sinovac)
DC has dropped its mask mandate. Why I and others think that - with an endemic virus - very justified to do this. Would recommend older people & immunocompromised get boosters & to mask indoors in mixed venues this winter if live in place with cases up washingtonpost.com/video/national…
Moreover, we are in unique situation in US where 1) highly vax'd places (like Bay Area) still have remaining mask mandates (except Marin, which is going by hospitalization data); 2) we are now finally acknowledging as public health community vax >>masks so let's motivate vax!
Finally, our group seeing 3 patterns worldwide where severe illness low: 1) high natural immunity (tragically gained, India); 2) high vax rate >75%; 3) lots of hybrid immunity (UK opened 7/19 in midst delta surge but with lots of vax). Maybe 3rd shot Covaxin? whole virus?
Poll: 74% of Americans Say Lives Have Returned to 'Normal' - very happy to see the confidence many in the US have in the vaccines, despite both 1) misinformation; 2) fearful messaging from some public health officials that they don't work well (they do!) medscape.com/viewarticle/96…
Mistaken messages on if vaccines reduce transmission (they do) and if vaccines are working during booster conversation (they do) eroded confidence in the vaccines
Cases used to track with hospitalizations but not now after vaccines- so we should now track hospitalizations to track the pandemic, not cases. Places with very high vax (80%), lots of natural immunity (sadly like India), hybrid immunity (UK) doing best